These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27403140)

  • 1. Positive correlation between plasma PCSK9 and tissue factors levels in patients with angiographically diagnosed coronary artery disease and diabetes mellitus.
    Wang M; Li YF; Guo YG; Chen MM; Jiang ZL; Song JY
    J Geriatr Cardiol; 2016 May; 13(4):312-5. PubMed ID: 27403140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma small dense LDL cholesterol with PCSK9 levels in patients with angiographically proven coronary artery disease.
    Zhang Y; Xu RX; Li S; Zhu CG; Guo YL; Sun J; Li JJ
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):426-33. PubMed ID: 25770756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
    Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
    Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status.
    Li S; Xu RX; Zhang Y; Guo YL; Zhu CG; Liu G; Dong Q; Li JJ
    J Endocrinol Invest; 2015 Dec; 38(12):1291-9. PubMed ID: 26003826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
    Hu D; Yang Y; Peng DQ
    Int J Cardiol; 2017 Jan; 227():61-65. PubMed ID: 27846466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease.
    Nozue T; Hattori H; Ogawa K; Kujiraoka T; Iwasaki T; Hirano T; Michishita I
    Lipids Health Dis; 2016 Sep; 15(1):165. PubMed ID: 27658826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between plasma levels of PCSK9 and the presence of coronary artery disease in Japanese.
    Nose D; Shiga Y; Ueda Y; Idemoto Y; Tashiro K; Suematsu Y; Kuwano T; Kitajima K; Saku K; Miura SI
    Heart Vessels; 2019 Jan; 34(1):19-28. PubMed ID: 29974199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease.
    Zhang Y; Zhu CG; Xu RX; Li S; Guo YL; Sun J; Li JJ
    J Clin Lipidol; 2014; 8(5):494-500. PubMed ID: 25234562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease.
    Li S; Guo YL; Xu RX; Zhang Y; Zhu CG; Sun J; Qing P; Wu NQ; Jiang LX; Li JJ
    Atherosclerosis; 2014 Jun; 234(2):441-5. PubMed ID: 24769476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Li S; Zhang Y; Li XL; Guo YL; Zhu CG; Li JJ
    Lipids Health Dis; 2014 Dec; 13():188. PubMed ID: 25496400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia.
    Brouwers MC; Konrad RJ; van Himbergen TM; Isaacs A; Otokozawa S; Troutt JS; Schaefer EJ; van Greevenbroek MM; Stalenhoef AF; de Graaf J
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1115-21. PubMed ID: 23333725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of serum PCSK9 in CHD patients with the severity of coronary arterial lesions.
    Wang S; Cheng ZY; Zhao ZN; Quan XQ; Wei Y; Xia DS; Li JQ; Hu JL
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1135-9. PubMed ID: 27049268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum PCSK9 levels, but not PCSK9 polymorphisms, are associated with CAD risk and lipid profiles in southern Chinese Han population.
    Cai G; Yu L; Huang Z; Li L; Fu X
    Lipids Health Dis; 2018 Sep; 17(1):213. PubMed ID: 30205809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease.
    Li S; Zhang Y; Xu RX; Guo YL; Zhu CG; Wu NQ; Qing P; Liu G; Dong Q; Li JJ
    Ann Med; 2015; 47(5):386-93. PubMed ID: 26153823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the association between plasma PCSK9 and Lp(a) in Han Chinese.
    Yang SH; Li S; Zhang Y; Xu RX; Zhu CG; Guo YL; Wu NQ; Qing P; Gao Y; Cui CJ; Dong Q; Sun J; Li JJ
    J Endocrinol Invest; 2016 Aug; 39(8):875-83. PubMed ID: 26894681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk.
    Arsenault BJ; Petrides F; Tabet F; Bao W; Hovingh GK; Boekholdt SM; Ramin-Mangata S; Meilhac O; DeMicco D; Rye KA; Waters DD; Kastelein JJP; Barter P; Lambert G
    J Clin Lipidol; 2018; 12(1):130-136. PubMed ID: 29103916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum proprotein convertase subtilisin/kexin type 9 with early atherosclerosis in newly diagnosed type 2 diabetes mellitus.
    Guo W; Gong Y; Li J; Qin P; Lu J; Li X; Zhu W; Xu N; Zhou H; Zhang Q
    Nutr Metab Cardiovasc Dis; 2019 Aug; 29(8):815-821. PubMed ID: 31133497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma proprotein convertase subtilisin/kexin type 9 is associated with Lp(a) in type 2 diabetic patients.
    Nekaies Y; Baudin B; Kelbousi S; Sakly M; Attia N
    J Diabetes Complications; 2015; 29(8):1165-70. PubMed ID: 26412029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia.
    Cao YX; Liu HH; Sun D; Jin JL; Xu RX; Guo YL; Wu NQ; Zhu CG; Li S; Zhang Y; Sun J; Li JJ
    Atherosclerosis; 2018 Oct; 277():7-14. PubMed ID: 30170223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCSK9 and atherosclerosis burden in the coronary arteries of patients undergoing coronary angiography.
    Panahi Y; Ghahrodi MS; Jamshir M; Safarpour MA; Bianconi V; Pirro M; Farahani MM; Sahebkar A
    Clin Biochem; 2019 Dec; 74():12-18. PubMed ID: 31493378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.